The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

Pfizer Inc. (NYSE: PFE) will present the latest results from its leading genitourinary (GU) portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium taking ...

When they accumulate, they can jeopardize the patients’ recovery. Now, a UB-led study describes for the first time a molecular mechanism that could drive the design of strategies to eliminate ...

(4) High activity against colon and pancreatic cancer cells that bear K-RAS and/or TP53 mutations. (5) High effectiveness against hormone refractory prostate cancer. (6) High effectiveness against ...

Now, a UB-led study describes for the first time a molecular mechanism that could drive the design of strategies to eliminate senescent cells in cancer patients. The study, published in the ...

Research suggests that alcohol causes cancer through at least five different mechanisms. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

Cite this: Frequency Format Diagram and Probability Chart for Breast Cancer Risk Communication: A Prospective, Randomized Trial - Medscape - Oct 20, 2008.

KEGG enrichment analysis identified the cell cycle as key mechanisms through which PB acts against BC. Blocking the tumor cell cycle is a well-established anti-cancer strategy. We first examined the ...

"Pelareorep has the potential to meaningfully improve outcomes for patients with metastatic pancreatic cancer," said Thomas Heineman, M.D., Ph.D., Chief Medical Officer for Oncolytics Biotech.